Showing results (311-320 of 343) with videos related to
Sort By:
Pageof 35
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1997
Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramineR F Schäfers, U Poller, K Pönicke, et al.Molecular Pharmacology|March 1, 1989
[3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic siteM C Michel, O E Brodde, B Schnepel, et al.Clinical Chemistry|January 21, 2016
Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary AldosteronismGraeme Eisenhofer, Tanja Dekkers, Mirko Peitzsch, et al.Biochemical Pharmacology|April 6, 1993
Tissue- and subunit-specific regulation of G-protein expression by hypo- and hyperthyroidismM B Michel-Reher, G Gross, J R Jasper, et al.Pharmacogenetics|August 16, 2001
Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein beta3 subunitR F Schäfers, J Nürnberger, A Rütz, et al.British Journal of Clinical Pharmacology|March 12, 1999
Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosinR F Schäfers, B Fokuhl, A Wasmuth, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1993
Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atriumH R Zerkowski, A Broede, K Kunde, et al.The Journal of Biological Chemistry|July 25, 1993
The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophyK U Knowlton, M C Michel, M Itani, et al.European Journal of Pharmacology|January 7, 1999
Alpha2B-adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systemsC I Holmberg, J P Kukkonen, A Bischoff, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|June 21, 2001
In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptorsM Eltze, R Boer, M C Michel, et al.Pageof 35